Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 1/2012

01-01-2012 | Original Paper

99 mTc-MIBI washout as a complementary factor in the evaluation of idiopathic dilated cardiomyopathy (IDCM) using myocardial perfusion imaging

Authors: Mohammad Kazem Shiroodi, Babak Shafiei, Nastaran Baharfard, Mohammad Esmail Gheidari, Babak Nazari, Elaheh Pirayesh, Ali Kiasat, Samaneh Hoseinzadeh, Abolghassem Hashemi, Mohammad Ali Akbarzadeh, Hamid Javadi, Iraj Nabipour, Majid Assadi

Published in: The International Journal of Cardiovascular Imaging | Issue 1/2012

Login to get access

Abstract

Rapid technetium-99 m methoxyisobutylisonitrile (99 mTc-MIBI) washout has been shown to occur in impaired myocardia. This study is based on the hypothesis that scintigraphy can be applied to calculate the myocardial 99 mTc-MIBI washout rate (WR) to diagnose and evaluate heart failure severity and other left ventricular functional parameters specifically in idiopathic dilated cardiomyopathy (IDCM) patients. Patients with IDCMP (n = 17; 52.65 ± 11.47 years) and normal subjects (n = 6; 49.67 ± 10.15 years) were intravenously administered 99 mTc-hexakis-2-methoxyisobutylisonitrile (99 mTc-MIBI). Next, early and delayed planar data were acquired (at 3.5-h intervals), and electrocardiogram (ECG)-gated myocardial perfusion single photon emission computed tomography (SPECT) was performed. The 99 mTc-MIBI WR was calculated using early and delayed planar images. Left ventricular functional parameters were also analyzed using quantitative gated SPECT (QGS) data. In target group, myocardial WRs (29.13 ± 6.68%) were significantly higher than those of control subjects (14.17 ± 3.31%; P < 0.001). The 99 mTc-MIBI WR increased with the increasing severity of the NYHA functional class (23.16 ± 1.72% for class I, 30.25 ± 0.95% for class II, 32.60 ± 6.73% for class III, and 37.50 ± 7.77% for class IV; P = 0.02). The WR was positively correlated with the end-diastolic volume (EDV) index (r 2 = 0.216; β = 0.464; P = 0.02 [ml/m2], the end-systolic volume (ESV) index (r 2 = 0.234; β = 0.484; P = 0.01 [ml/m2]), the summed motion score (SMS) (r 2 = 0.544; β = 0.738; P = 0.00), and the summed thickening score (STS) (r 2 = 0.656; β = 0.810; P = 0.00); it was negatively correlated with the left ventricular ejection fraction (LVEF) (r 2 = 0.679; β = –0.824; P = 0.00). It can be concluded that 99 mTc-MIBI scintigraphy might be a valuable molecular imaging tool for the diagnosis and evaluation of myocardial damage or dysfunction severity.
Literature
1.
go back to reference Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084PubMedCrossRef Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084PubMedCrossRef
2.
go back to reference Knaapen P, Boellaard R, Gotte MJ, Dijkmans PA, van Campen LM, de Cock CC, Luurtsema G, Visser CA, Lammertsma AA, Visser FC (2004) Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 45:1299–1304PubMed Knaapen P, Boellaard R, Gotte MJ, Dijkmans PA, van Campen LM, de Cock CC, Luurtsema G, Visser CA, Lammertsma AA, Visser FC (2004) Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 45:1299–1304PubMed
4.
go back to reference Grieve DJ, Shah AM (2003) Oxidative stress in heart failure. More than just damage. Eur Heart J 24:2161–2163PubMedCrossRef Grieve DJ, Shah AM (2003) Oxidative stress in heart failure. More than just damage. Eur Heart J 24:2161–2163PubMedCrossRef
5.
go back to reference Ikawa M, Kawai Y, Arakawa K, Tsuchida T, Miyamori I, Kuriyama M, Tanaka M, Yoneda M (2007) Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch. Mitochondrion 7:164–170PubMedCrossRef Ikawa M, Kawai Y, Arakawa K, Tsuchida T, Miyamori I, Kuriyama M, Tanaka M, Yoneda M (2007) Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch. Mitochondrion 7:164–170PubMedCrossRef
6.
go back to reference Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M (1998) Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153:1501–1510PubMedCrossRef Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M (1998) Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153:1501–1510PubMedCrossRef
7.
go back to reference Feigenbaum A, Bai RK, Doherty ES, Kwon H, Tan D, Sloane A, Cutz E, Robinson BH, Wong LJ (2006) Novel mitochondrial DNA mutations associated with myopathy, cardiomyopathy, renal failure, and deafness. Am J Med Genet A 140:2216–2222PubMed Feigenbaum A, Bai RK, Doherty ES, Kwon H, Tan D, Sloane A, Cutz E, Robinson BH, Wong LJ (2006) Novel mitochondrial DNA mutations associated with myopathy, cardiomyopathy, renal failure, and deafness. Am J Med Genet A 140:2216–2222PubMed
8.
go back to reference Lev D, Nissenkorn A, Leshinsky-Silver E, Sadeh M, Zeharia A, Garty BZ, Blieden L, Barash V, Lerman-Sagie T (2004) Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol 25:443–450PubMedCrossRef Lev D, Nissenkorn A, Leshinsky-Silver E, Sadeh M, Zeharia A, Garty BZ, Blieden L, Barash V, Lerman-Sagie T (2004) Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol 25:443–450PubMedCrossRef
9.
go back to reference Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516–1522PubMed Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516–1522PubMed
10.
go back to reference Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D’Amati G, Liu PP (1990) Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 82:1802–1814PubMedCrossRef Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D’Amati G, Liu PP (1990) Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 82:1802–1814PubMedCrossRef
11.
go back to reference Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C (1993) Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20:20–25PubMedCrossRef Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C (1993) Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20:20–25PubMedCrossRef
12.
go back to reference Liu Z, Johnson G III, Beju D, Okada RD (2001) Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics. J Nucl Cardiol 8:677–686PubMedCrossRef Liu Z, Johnson G III, Beju D, Okada RD (2001) Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics. J Nucl Cardiol 8:677–686PubMedCrossRef
13.
go back to reference Haq IU, Ramsay LE, Jackson PR, Wallis EJ (1996) National heart foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia advisory group on behalf of the scientific committee of the national heart foundation of New Zealand. N Z Med J 109:224–231 Haq IU, Ramsay LE, Jackson PR, Wallis EJ (1996) National heart foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia advisory group on behalf of the scientific committee of the national heart foundation of New Zealand. N Z Med J 109:224–231
14.
go back to reference Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, Somsen GA, Unlu M, Verberne HJ (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European council of nuclear cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812PubMedCrossRef Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, Somsen GA, Unlu M, Verberne HJ (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European council of nuclear cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812PubMedCrossRef
15.
go back to reference Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317:1098PubMed Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317:1098PubMed
16.
go back to reference Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y (2006) Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 13:64–68PubMedCrossRef Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y (2006) Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 13:64–68PubMedCrossRef
17.
go back to reference Piwnica-Worms D, Kronauge JF, Chiu ML (1990) Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82:1826–1838PubMedCrossRef Piwnica-Worms D, Kronauge JF, Chiu ML (1990) Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82:1826–1838PubMedCrossRef
18.
go back to reference Kumita S, Seino Y, Cho K, Nakajo H, Toba M, Fukushima Y, Okamoto N, Takano T, Kumazaki T (2002) Assessment of myocardial washout of Tc-99m-sestamibi in patients with chronic heart failure: comparison with normal control. Ann Nucl Med 16:237–242PubMedCrossRef Kumita S, Seino Y, Cho K, Nakajo H, Toba M, Fukushima Y, Okamoto N, Takano T, Kumazaki T (2002) Assessment of myocardial washout of Tc-99m-sestamibi in patients with chronic heart failure: comparison with normal control. Ann Nucl Med 16:237–242PubMedCrossRef
19.
go back to reference Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M (2007) A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol 14:215–220PubMedCrossRef Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M (2007) A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol 14:215–220PubMedCrossRef
20.
go back to reference Piwnica-Worms D, Chiu ML, Kronauge JF (1992) Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation 85:1531–1541PubMed Piwnica-Worms D, Chiu ML, Kronauge JF (1992) Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation 85:1531–1541PubMed
21.
go back to reference Sato T, Kawabata Y, Nitta T, Saigo Y, Iwashita Y, Suenaga S, Hamahira S, Indo H, Morita Y, Majima HJ, Sugihara K (2005) Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck. Dentomaxillofac Radiol 34:274–278PubMedCrossRef Sato T, Kawabata Y, Nitta T, Saigo Y, Iwashita Y, Suenaga S, Hamahira S, Indo H, Morita Y, Majima HJ, Sugihara K (2005) Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck. Dentomaxillofac Radiol 34:274–278PubMedCrossRef
22.
go back to reference Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218PubMedCrossRef Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218PubMedCrossRef
23.
go back to reference Wu YW, Yen RF, Chieng PU, Huang PJ (2003) Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardiol 10:369–374PubMedCrossRef Wu YW, Yen RF, Chieng PU, Huang PJ (2003) Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardiol 10:369–374PubMedCrossRef
24.
go back to reference Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, Kang X, Friedman JD, Germano G, Berman DS (2003) Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 42:1818–1825PubMedCrossRef Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, Kang X, Friedman JD, Germano G, Berman DS (2003) Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 42:1818–1825PubMedCrossRef
25.
go back to reference Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital mobility project on familial dilated cardiomyopathy. Eur Heart J 20:93–102PubMedCrossRef Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital mobility project on familial dilated cardiomyopathy. Eur Heart J 20:93–102PubMedCrossRef
26.
go back to reference Danias PG, Ahlberg AW, Clark BA III, Messineo F, Levine MG, McGill CC, Mann A, Clive J, Dougherty JE, Waters DD, Heller GV (1998) Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 82:1253–1258PubMedCrossRef Danias PG, Ahlberg AW, Clark BA III, Messineo F, Levine MG, McGill CC, Mann A, Clive J, Dougherty JE, Waters DD, Heller GV (1998) Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 82:1253–1258PubMedCrossRef
27.
go back to reference Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, Gensini G, Pupi A, Padeletti L (2004) Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 45:164–168PubMed Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, Gensini G, Pupi A, Padeletti L (2004) Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 45:164–168PubMed
Metadata
Title
99 mTc-MIBI washout as a complementary factor in the evaluation of idiopathic dilated cardiomyopathy (IDCM) using myocardial perfusion imaging
Authors
Mohammad Kazem Shiroodi
Babak Shafiei
Nastaran Baharfard
Mohammad Esmail Gheidari
Babak Nazari
Elaheh Pirayesh
Ali Kiasat
Samaneh Hoseinzadeh
Abolghassem Hashemi
Mohammad Ali Akbarzadeh
Hamid Javadi
Iraj Nabipour
Majid Assadi
Publication date
01-01-2012
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 1/2012
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9770-5

Other articles of this Issue 1/2012

The International Journal of Cardiovascular Imaging 1/2012 Go to the issue